MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129 | -89.9% | 101,788 | -73.7% | 0.01% | -91.3% |
| Q2 2023 | $1,275 | +51.8% | 387,591 | +89.6% | 0.13% | +53.0% |
| Q1 2023 | $840 | +344.4% | 204,476 | +534.2% | 0.08% | +260.9% |
| Q4 2022 | $189 | -100.0% | 32,241 | -80.7% | 0.02% | -84.7% |
| Q3 2022 | $1,129,000 | +44.7% | 166,992 | -1.0% | 0.15% | +28.2% |
| Q2 2022 | $780,000 | +148.4% | 168,744 | +114.4% | 0.12% | +178.6% |
| Q1 2022 | $314,000 | -42.1% | 78,706 | -9.6% | 0.04% | -38.2% |
| Q4 2021 | $542,000 | +155.7% | 87,065 | +863.2% | 0.07% | -42.4% |
| Q2 2020 | $212,000 | – | 9,039 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,005,600 | $64,810,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,695,667 | $59,796,000 | 3.39% |
| COMMODORE CAPITAL LP | 429,228 | $6,945,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 357,689 | $5,787,000 | 2.09% |
| Avoro Capital Advisors LLC | 6,800,000 | $110,024,000 | 1.90% |
| Ghost Tree Capital, LLC | 450,000 | $7,281,000 | 1.71% |
| RHO CAPITAL PARTNERS INC | 796,458 | $12,887,000 | 1.24% |
| Rock Springs Capital Management LP | 2,775,127 | $44,902,000 | 0.98% |
| Sio Capital Management, LLC | 157,259 | $2,544,000 | 0.52% |
| Bellevue Group AG | 2,850,010 | $46,113,000 | 0.49% |